Patient Education in Pregnant Women With Asthma

Pregnancy may impact treatment adherence in women with asthma. This is a major risk factor for asthma exacerbation, which may have an important impact for both women and the babies. This study aims to evaluate the impact of a targeted patient education action tailored for pregnant women with asthma.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Chu Reims

Reims, 51092, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult pregnant women with asthma

Exclusion criteria

women not able to speak and/or read French language
women protected by the law

Treatment and study plan

Follow-up

Other

Questionnaire of Quality of life

Primary outcomes

Change from Asthma quality of life between two periods : before intervention and 3 month after the intervention

Time frame: before and 3 month after the intervention

The physician gives Asthma quality of life questionnaire (AQLQ) before intervention and 3 month after the intervention

Sponsors and collaborators

Lead sponsor

CHU de Reims

Other

Registry information

Official study title

Patient Education: Asthma and Pregnancy

Acronym: TAPAGE

Important dates

Study start: 2022
Primary completion: 2023
Study completion: 2023
First posted: Jul 14, 2022
Registry last updated: Nov 21, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed